Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Ixabepilone

Ixabepilone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Ixabepilone

39 trials tracked of Ixabepilone: 4 in phase 3 or 4.

39Trials tracked
4Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 4 Phase 2 30 Phase 1 5
  1. Phase 3 Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer Completed
  2. Phase 3 A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer Completed
  3. Phase 3 Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Completed
  4. Phase 3 A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine Completed
  5. Phase 2 A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas Completed
  6. Phase 2 Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer Completed
Show 33 more trials
  1. Phase 2 Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy Completed
  2. Phase 2 Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy Completed
  3. Phase 2 Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Completed
  4. Phase 2 Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer Completed
  5. Phase 2 Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons Completed
  6. Phase 2 Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer Completed
  7. Phase 2 Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer After Anthracycline Failure (CAT) Completed
  8. Phase 2 A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer Completed
  9. Phase 2 Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer Completed
  10. Phase 2 Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Completed
  11. Phase 2 Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab Completed
  12. Phase 2 Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer Completed
  13. Phase 2 Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer Completed
  14. Phase 2 Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer Completed
  15. Phase 2 A Study of LY2523355 in Participants With Breast Cancer Completed
  16. Phase 2 Neo-Adjuvant Study in Triple Negative Breast Cancer Patients Completed
  17. Phase 2 Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer Completed
  18. Phase 2 Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer Completed
  19. Phase 2 A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer Completed
  20. Phase 2 Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy Completed
  21. Phase 2 Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer Completed
  22. Phase 2 Ixabepilone + Carboplatin Metastatic Breast Cancer Completed
  23. Phase 2 Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer Completed
  24. Phase 2 Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer Completed
  25. Phase 2 Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer Completed
  26. Phase 2 A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer Completed
  27. Phase 2 Ixabepilone in Treating Patients With Metastatic Prostate Cancer Completed
  28. Phase 2 Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer Completed
  29. Phase 1 Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies. Completed
  30. Phase 1 A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Cancer Completed
  31. Phase 1 Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer Completed
  32. Phase 1 Phase I Combination Ixabepilone + Cisplatin Completed
  33. Phase 1 Phase I Combination w/ Epirubicin Completed

Showing the 39 most-cited and recently-updated of 39 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.